Assessing the Accuracy of the RevK Sensor

Assessing the Accuracy of the RevK Sensor for Non-Invasive Hemoglobin Monitoring

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01877876

Enrollment

Registered

2013-06-14

Start date

2013-06-30

Completion date

2015-06-30

Last updated

2015-06-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients Undergoing Spine Surgery

Brief summary

Evaluation of a new generation of sensors for monitoring blood hemoglobin. The newest version is RevK.

Detailed description

Evaluation of a new generation of sensors for monitoring blood hemoglobin with the Masimo non-invasive hemoglobin monitor. The newest sensor version is RevK.

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Healthy volunteers

Inclusion criteria

* Male or non-pregnant female * American Society of Anesthesiology Classification 1, 2 or 3 * Scheduled to undergo spine or hip surgery

Exclusion criteria

* Pregnant or nursing * Patients who in the study investigators clinical judgement would not be suitable for research

Design outcomes

Primary

Measure	Time frame	Description
To assess the accuracy of the RevK sensor for measuring blood hemoglobin compared to a laboratory-derived hemoglobin value.	Intermittently during spine surgery	Primary outcome is based on the difference between a value from the SpHb (Masimo SpHb™ continuous hemoglobin reading) minus tHb (laboratory hemoglobin determination).

Countries

United States

Outcome results